Consumo de Ertapenem y Linezolid en el servicio de infectología del Hospital Alta Complejidad Virgen de la Puerta- EsSalud, en el periodo 2018-2019
No Thumbnail Available
Date
2021
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Nacional de Trujillo
Abstract
El presente informe tuvo como objetivo determinar el consumo de Ertapenem y Linezolid en el servicio de Infectología del Hospital Alta Complejidad Virgen de la Puerta- EsSalud, en el periodo 2018-2019. Se determinó el consumo mediante la metodología DDD/100camas/día de Ertapenem y Linezolid. La información se obtuvo de los registros informatizados de los medicamentos consumidos por pacientes hospitalizados de ambos sexos, durante el periodo 2018-2019. La tendencia del consumo de ertapenem en el Servicio de Infectologia es a incrementar en el tiempo (r = 0.5255). La tendencia del consumo de Linezolid en el Servicio de Infectología es a incrementar en el tiempo (r=0,4512). El consumo de Ertapenem y Linezolid en 2018 y 2019 ocasionó un gasto total de 198440.15 y 73431.5 respectivamente
ABSTRACT The objective of this report was to determine the consumption of Ertapenem and Linezolid in the Infectious Diseases department of Hospital Alta Complejidad Virgen de la Puerta-EsSalud, in the period 2018-2019. Consumption was determined using the DDD / 100beds / day methodology of Ertapenem and Linezolid. The information was obtained from the computerized records of the drugs consumed by hospitalized patients of both sexes, during the period 2018-2019. The trend of ertapenem consumption in the Infectology Service is to increase over time (r = 0.5255). The trend of Linezolid consumption in the Infectology Service is to increase over time (r = 0.4512). The consumption of Ertapenem and Linezolid in 2018 and 2019 caused a total expenditure of 198440.15 and 73.431.5 respectively
ABSTRACT The objective of this report was to determine the consumption of Ertapenem and Linezolid in the Infectious Diseases department of Hospital Alta Complejidad Virgen de la Puerta-EsSalud, in the period 2018-2019. Consumption was determined using the DDD / 100beds / day methodology of Ertapenem and Linezolid. The information was obtained from the computerized records of the drugs consumed by hospitalized patients of both sexes, during the period 2018-2019. The trend of ertapenem consumption in the Infectology Service is to increase over time (r = 0.5255). The trend of Linezolid consumption in the Infectology Service is to increase over time (r = 0.4512). The consumption of Ertapenem and Linezolid in 2018 and 2019 caused a total expenditure of 198440.15 and 73.431.5 respectively
Description
Keywords
Prácticas pre profesionales. Linezolid. Ertapenem. Consumo.